- Home
- WTBA vs JSPR Comparison
WTBA vs JSPR Comparison
Compare WTBA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | JSPR |
|---|---|---|
| Founded | 1893 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 26.3M |
| IPO Year | 2002 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WTBA | JSPR |
|---|---|---|
| Price | $29.37 | $0.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $24.00 | $15.50 |
| AVG Volume (30 Days) | 52.0K | ★ 604.9K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | 19.22 |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | $22.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.03 | $0.32 |
| 52 Week High | $30.33 | $2.69 |
Technical Indicators
Market Signals| Indicator | WTBA | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 57.03 | 49.62 |
| Support Level | $27.54 | $0.64 |
| Resistance Level | $30.33 | $1.01 |
| Average True Range (ATR) | 0.53 | 0.05 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 80.83 | 66.21 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.